HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CIR Adds To Hair-Care Ingredients On 2015 Priority Review List

This article was originally published in The Rose Sheet

Executive Summary

CIR adds hair-dye ingredient 1-hydroxyethyl-4,5-diamino pyrazole sulfate and conditioning agent hydrolyzed keratin to its 2015 priority review list, which was approved during the Expert Panel’s June 9-10 meeting in Washington D.C. The panel issued final safety reports for seven ingredients and gave tentative final reports for eight substances.

You may also be interested in...



CIR’s Draft Ingredient List For 2015 Review Raises No Red Flags

The CIR Expert Panel released its draft list of 22 cosmetic ingredients/ingredient groups targeted for review in 2015, all low-hazard substances according to the Environmental Working Group’s Skin Deep website. CIR introduced the draft roster ahead of schedule to allow more time for public input, and will issue a final priority list in June.

CIR: New Research On Controversial Ingredients Should Be Considered

The Cosmetic Ingredient Review Expert Panel will take a look at new research on cosmetic ingredients as needed, even if an ingredient in question is not up for review.

SCCP Concludes Additional Data Is Needed On Hair Dye, UV Filters

An in vitro percutaneous absorption study under oxidative conditions is among the data needed to determine the safety of hair dye ingredient 1-hydroxyethyl-4,5-diamino pyrazole sulfate, the EU's Scientific Committee on Consumer Products concludes in an 1opinion adopted during its June 20 plenary session

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019079

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel